▁in ▁scientific ▁research ▁before ▁being ▁sold ▁as ▁a ▁designer ▁drug ▁in ▁the ▁mid - 2 0 0 0 s . ▁It ▁has ▁been ▁detected ▁in ▁p ills ▁tout ed ▁as ▁legal ▁alternatives ▁to ▁ill ic it ▁stim ul ants ▁in ▁New ▁Zealand ▁and ▁p ills ▁sold ▁as ▁" ec st asy " ▁in ▁Europe ▁and ▁the ▁United ▁States . ▁ ▁Despite ▁its ▁advert is ement ▁as ▁a ▁recre ational ▁subst ance , ▁m CP P ▁is ▁actually ▁generally ▁considered ▁to ▁be ▁an ▁un ple asant ▁experience ▁and ▁is ▁not ▁desired ▁by ▁drug ▁users . ▁It ▁la cks ▁any ▁rein for cing ▁or ▁hall uc in ogen ic ▁effects , ▁produces ▁d ys ph or ic , ▁de press ive , ▁and ▁an xi ogen ic ▁effects ▁in ▁rod ents ▁and ▁humans , ▁and ▁can ▁indu ce ▁pan ic ▁attacks ▁in ▁individuals ▁sus cept ible ▁to ▁them . ▁It ▁also ▁w ors ens ▁obs ess ive – comp uls ive ▁sympt oms ▁in ▁people ▁with ▁the ▁dis order . ▁ ▁m CP P ▁is ▁known ▁to ▁indu ce ▁head aches ▁in ▁humans ▁and ▁has ▁been ▁used ▁for ▁testing ▁potential ▁ant im ig raine ▁medic ations . ▁It ▁has ▁pot ent ▁an ore ctic ▁effects ▁and ▁has ▁encourag ed ▁the ▁development ▁of ▁select ive ▁ 5 - HT 2 C ▁re ceptor ▁ag on ists ▁for ▁the ▁treatment ▁of ▁ob es ity ▁as ▁well . ▁ ▁Ph arm ac ology ▁ ▁Ph arm ac od ynam ics ▁ ▁m CP P ▁poss esses ▁significant ▁aff